TY - JOUR
T1 - Proposed reporting guideline for dose-response meta-analysis (Chinese edition)
AU - Xu, Chang
AU - Doi, Suhail A.R.
AU - Zhang, Chao
AU - Sun, Xin
AU - Chen, Hao
AU - Zhou, Quan
AU - Yuan, Rui Xia
AU - Guo, Peng
AU - Zhang, Long Hao
AU - Niu, Yu Ming
AU - Kwong, Joey S.W.
AU - Liu, Tong Zu
N1 - Publisher Copyright:
© 2016 Editorial Board of Chin J Evid-based Med.
PY - 2016
Y1 - 2016
N2 - Objective To develop reporting guideline for dose-response meta-analysis (DMA), so as to help Chinese authors to understand DMA better and to promote the reporting quality of DMA conducted by them. Method PubMed, EMbase, The Cochrane Library, CNKI, and WanFang Data were searched from Jan 1st 2011 to Dec 30th 2015 to collect DMA papers published by Chinese authors. The number of these publications by years, whether and what kind of reporting guideline was used, and whether the DMA method claimed in these publications was correct were analysed. Then we drafted a checklist of items for reporting DMA, and organized a discussion meeting with experts from the fields of DMA, evidence-based medicine, clinical epidemiology, and clinicians to collect suggestions for revising the draft reporting guideline for DMA. Results Only 33.73% of the publications clarified it is a DMA on the title and 48.02% of them reported risk of bias. Almost 38.49% of the publications didn't use any reporting guidelines. Fourteen of them claimed an incorrect use of methodology. We primarily took account for 47 potential items related to DMA based on our literature analysis results and existing reporting guidelines for other types of meta-analyses. After the discussion meeting with 6 experts, we revised the items, and finally the G-Dose checklist with 43 items for reporting DMA was developed. Conclusion There is a lack of attention on reporting guidelines in Chinese authors and evidence suggests these authors may be at risk of incomplete understanding on reporting guidelines. It is strongly recommended to use reporting guidelines for DMA and other types of meta-analyses in Chinese authors.
AB - Objective To develop reporting guideline for dose-response meta-analysis (DMA), so as to help Chinese authors to understand DMA better and to promote the reporting quality of DMA conducted by them. Method PubMed, EMbase, The Cochrane Library, CNKI, and WanFang Data were searched from Jan 1st 2011 to Dec 30th 2015 to collect DMA papers published by Chinese authors. The number of these publications by years, whether and what kind of reporting guideline was used, and whether the DMA method claimed in these publications was correct were analysed. Then we drafted a checklist of items for reporting DMA, and organized a discussion meeting with experts from the fields of DMA, evidence-based medicine, clinical epidemiology, and clinicians to collect suggestions for revising the draft reporting guideline for DMA. Results Only 33.73% of the publications clarified it is a DMA on the title and 48.02% of them reported risk of bias. Almost 38.49% of the publications didn't use any reporting guidelines. Fourteen of them claimed an incorrect use of methodology. We primarily took account for 47 potential items related to DMA based on our literature analysis results and existing reporting guidelines for other types of meta-analyses. After the discussion meeting with 6 experts, we revised the items, and finally the G-Dose checklist with 43 items for reporting DMA was developed. Conclusion There is a lack of attention on reporting guidelines in Chinese authors and evidence suggests these authors may be at risk of incomplete understanding on reporting guidelines. It is strongly recommended to use reporting guidelines for DMA and other types of meta-analyses in Chinese authors.
KW - Cross-sectional analysis
KW - Dose-response meta-analysis
KW - Reporting guideline
UR - http://www.scopus.com/inward/record.url?scp=85048045736&partnerID=8YFLogxK
U2 - 10.7507/1672-2531.20160185
DO - 10.7507/1672-2531.20160185
M3 - Article
SN - 1672-2531
VL - 16
SP - 1221
EP - 1226
JO - Chinese Journal of Evidence-Based Medicine
JF - Chinese Journal of Evidence-Based Medicine
IS - 10
ER -